US HEALTHCARE company Johnson & Johnson has confirmed it is in discussions with Swiss-listed blue-chip company Actelion around a potential transaction.
The companies have said they would make no further comment until there is a definite deal.
The above article was sent to subscribers in Pharmacy Daily's issue from 29 Nov 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Nov 16